Q stem Co., Ltd

Based in South Korea, Qstem Co. , Ltd. operates in the biotechnology sector, specializing in the development and commercialization of advanced stem cell technologies for therapeutic applications. Founded in 2024 and headquartered in Seoul, South Korea, Qstem Co.

, Ltd. focuses on innovative biotechnology solutions. The company has successfully completed two deals with its recent deal completed in February 2026, raising KRW 2. 2 billion in seed funding led by returning investor FuturePlay, with participation from new investors Mashup Ventures, Hallym University Technology Holdings, and AI Angel Club.

The company has not undergone any significant strategic pivots since its inception. No information about subsidiaries or parent companies is available. Qstem Co. , Ltd specializes in innovative biotechnology solutions, focusing on the development and commercialization of advanced stem cell technologies.

Their core products include proprietary stem cell culture systems designed to enhance cell growth and differentiation processes used in various therapeutic applications. These products are utilized extensively in research and clinical settings to address challenges in regenerative medicine, drug discovery, and disease modeling. Qstem serves a diverse clientele, including research institutions, pharmaceutical companies, and healthcare providers, particularly in North America, Europe, and parts of Asia. The revenue generation model of Qstem Co.

, Ltd is structured primarily around B2B sales of its stem cell products and technologies to research institutions and commercial partners. Transactions typically involve direct sales agreements and long-term partnerships where clients procure products on a recurring basis, ensuring a steady revenue stream. The company may offer tiered pricing plans based on volume purchases, allowing clients to opt for subscription-like arrangements for ongoing supply needs. Flagship products, integral to the company's portfolio, play a vital role in attracting new clients and retaining existing ones, fostering a sustainable business environment.

The company will use the February 2026 seed funding to further improve its platform for raw materials and broaden its product offerings for hair loss.